GLYMATE’s Global Strategy Opens a New Chapter:
Carrying the Gene of Regenerative Medicine, Innovative Plant-Based Biomimetic Skincare Series Launches Simultaneously in China and the U.S.
[Los Angeles] August 1, 2026 – Global health technology and regenerative medicine brand GLYMATE today announced the official launch of its next-generation Plant-Based Biomimetic Barrier Repair Skincare Series in both North America and Mainland China. This simultaneous Sino-U.S. launch represents not only the global debut of an innovative product, but also marks a new phase in GLYMATE’s global brand strategy, bringing regenerative medicine-inspired skincare technology to consumers around the world.
As an international brand under MEBO, GLYMATE carries forward over three decades of research in regenerative medicine. Staying true to the brand philosophy of “Life Regeneration Technology, Reshaping Healthy Beauty” and centered on the core promise to “Renew Your Skin,” the brand is dedicated to extending medical-grade scientific achievements into daily health and skincare, fulfilling the brand mission of “Inner Health, Outer Beauty.”
The brand traces its origins to MEBO Pharmaceutical Technology Group, founded in 1987 by Professor Xu Rongxiang and Ms. Li Li. The group has long been devoted to research on in-situ regeneration technology for human tissues and has built a global industrial system encompassing scientific research, pharmaceuticals, health foods, skincare products, and international trade. As a leading representative in the field of regenerative medicine, MEBO Moisturizing Burn Ointment has helped tens of millions of patients and has been registered and recognized in numerous countries and regions, creating an internationally influential foundation of scientific achievement and brand equity.
Carrying the Gene of Regenerative Medicine, Innovative Plant-Based Biomimetic Skincare Series Launches Simultaneously in China and the U.S.
Building on this scientific foundation, GLYMATE continually drives the translation of life science breakthroughs into the health consumer sector. The brand was formally established in Los Angeles, USA, in 2019 and entered the Chinese market in 2023. Its product portfolio covers two major systems: internal health management and topical skin repair. By 2025, GLYMATE’s topical products achieved a critical breakthrough, transitioning from clinical regenerative technologies to everyday skincare scenarios, offering modern consumers comprehensive health solutions that integrate technology, safety, and efficacy.
The GLYMATE Plant-Based Biomimetic Moisturizing and Soothing Essence Water, launched simultaneously in China and the U.S., is the core product of the brand’s topical line. The product focuses on repairing problem skin, targeting common concerns such as barrier damage, dryness and sensitivity, and microecological imbalance, redefining skincare logic through the lens of regenerative medicine. The product innovatively integrates plant biomimetic technology, skin barrier science, and the concept of the skin microecology. Featuring high concentrations of cactus extract, Wenzhou mandarin orange peel extract, multiple natural amino acids, and microecological nutrients, it is systematically developed around three key directions: “repairing the skin barrier, maintaining microecological balance, and enhancing natural moisturizing ability.”
Unlike traditional hydrating skincare products, GLYMATE has constructed an innovative plant-based biomimetic nutrient system, combining a quadruple repair mechanism—biomimetic sebum film, water film, biological barrier, and microecological barrier—to build a more complete and stable natural defense system for problem skin. This achieves a synergistic effect of moisturizing, soothing, repairing, and strengthening the barrier, truly helping the skin return to a healthy balance and renewing its appearance.
A brand representative stated: “GLYMATE not only focuses on surface-level improvements but aims to help the skin restore its own natural, healthy balance through continuous innovation in regenerative medicine and life sciences. We believe that the future of skincare will move from purely cosmetic approaches toward scientific health management, and GLYMATE is committed to being a key driver of this era. The newly launched Essence Water is our sincere effort to focus on repairing problem skin and fulfill our promise to ‘Renew Your Skin.’”
Choosing China and the U.S. as the markets for this simultaneous global new product launch fully demonstrates GLYMATE’s long-term commitment to the international market and its determination to execute a global strategy. North America stands as a key trendsetter for high-end skincare consumption, home to the most mature scientific evaluation systems and the most discerning consumers. China, as one of the world’s most dynamic beauty markets, possesses enormous demand for consumption upgrades and a deep appreciation for science-based skincare. Through these two international platforms, GLYMATE aims to share the wisdom of Eastern regenerative medicine and the achievements of modern life sciences with the world, exploring the future of healthy skincare together.
Going forward, GLYMATE will continue to leverage global R&D resources and its regenerative medicine innovation platform to expand its international market presence, translate more life science achievements into high-quality health products, empower health with technology, create beauty through regeneration, and usher in a new era of healthy skincare for consumers worldwide.
